Compare Piramal Healthcare with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs ALKEM LABORATORIES - Comparison Results

PIRAMAL ENTERPRISES     Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PIRAMAL ENTERPRISES ALKEM LABORATORIES PIRAMAL ENTERPRISES/
ALKEM LABORATORIES
 
P/E (TTM) x 18.4 - - View Chart
P/BV x 1.2 6.6 17.6% View Chart
Dividend Yield % 1.5 0.7 232.1%  

Financials

 PIRAMAL ENTERPRISES   ALKEM LABORATORIES
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-19
ALKEM LABORATORIES
Mar-16
PIRAMAL ENTERPRISES/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs3,3031,589 207.8%   
Low Rs1,7971,232 145.8%   
Sales per share (Unadj.) Rs716.5417.5 171.6%  
Earnings per share (Unadj.) Rs79.756.3 141.6%  
Cash flow per share (Unadj.) Rs107.964.7 166.8%  
Dividends per share (Unadj.) Rs28.0012.70 220.5%  
Dividend yield (eoy) %1.10.9 122.0%  
Book value per share (Unadj.) Rs1,477.5292.9 504.4%  
Shares outstanding (eoy) m184.45119.57 154.3%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x3.63.4 105.3%   
Avg P/E ratio x32.025.1 127.7%  
P/CF ratio (eoy) x23.621.8 108.4%  
Price / Book Value ratio x1.74.8 35.8%  
Dividend payout %35.122.6 155.7%   
Avg Mkt Cap Rs m470,292168,653 278.9%   
No. of employees `0007.8NA-   
Total wages/salary Rs m22,5049,171 245.4%   
Avg. sales/employee Rs Th16,899.4NM-  
Avg. wages/employee Rs Th2,877.7NM-  
Avg. net profit/employee Rs Th1,879.9NM-  
INCOME DATA
Net Sales Rs m132,15349,915 264.8%  
Other income Rs m3,1281,645 190.1%   
Total revenues Rs m135,28151,561 262.4%   
Gross profit Rs m66,2908,482 781.5%  
Depreciation Rs m5,2021,006 517.2%   
Interest Rs m44,097671 6,575.8%   
Profit before tax Rs m20,1198,451 238.1%   
Minority Interest Rs m3,194-114 -2,806.5%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8,6111,606 536.2%   
Profit after tax Rs m14,7016,731 218.4%  
Gross profit margin %50.217.0 295.2%  
Effective tax rate %42.819.0 225.2%   
Net profit margin %11.113.5 82.5%  
BALANCE SHEET DATA
Current assets Rs m122,74227,062 453.6%   
Current liabilities Rs m310,81015,324 2,028.3%   
Net working cap to sales %-142.323.5 -605.2%  
Current ratio x0.41.8 22.4%  
Inventory Days Days2367 34.7%  
Debtors Days Days3941 94.1%  
Net fixed assets Rs m116,90412,610 927.1%   
Share capital Rs m369239 154.3%   
"Free" reserves Rs m272,16134,490 789.1%   
Net worth Rs m272,53035,027 778.1%   
Long term debt Rs m270,1961,212 22,300.8%   
Total assets Rs m856,26154,387 1,574.4%  
Interest coverage x1.513.6 10.7%   
Debt to equity ratio x1.00 2,866.2%  
Sales to assets ratio x0.20.9 16.8%   
Return on assets %6.913.6 50.5%  
Return on equity %5.419.2 28.1%  
Return on capital %12.424.9 50.0%  
Exports to sales %012.9 0.0%   
Imports to sales %03.1 0.0%   
Exports (fob) Rs mNA6,461 0.0%   
Imports (cif) Rs mNA1,540 0.0%   
Fx inflow Rs m15,2006,563 231.6%   
Fx outflow Rs m4,8893,012 162.3%   
Net fx Rs m10,3123,552 290.3%   
CASH FLOW
From Operations Rs m-115,9757,259 -1,597.8%  
From Investments Rs m-8,2651,864 -443.4%  
From Financial Activity Rs m107,525-9,273 -1,159.6%  
Net Cashflow Rs m-16,650-150 11,100.1%  

Share Holding

Indian Promoters % 52.9 66.9 79.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.0 33.1 12.1%  
FIIs % 26.6 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 16.5 0.0 -  
Shareholders   93,274 68,381 136.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PIRAMAL ENTERPRISES With:   WOCKHARDT  J.B.CHEMICALS  ORCHID PHARMA LTD  BIOCON   FULFORD INDIA  

Compare PIRAMAL ENTERPRISES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY20); Net Profit Up 390.0% (Quarterly Result Update)

Aug 1, 2019 | Updated on Aug 1, 2019

For the quarter ended June 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (up 390.0% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 9, 2019 | Updated on Jul 9, 2019

Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.

PIRAMAL ENTERPRISES Announces Quarterly Results (4QFY19); Net Profit Down 91.4% (Quarterly Result Update)

Apr 30, 2019 | Updated on Apr 30, 2019

For the quarter ended March 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 3 bn (down 91.4% YoY). Sales on the other hand came in at Rs 37 bn (up 23.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (3QFY19); Net Profit Up 21.8% (Quarterly Result Update)

Jan 30, 2019 | Updated on Jan 30, 2019

For the quarter ended December 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 21.8% YoY). Sales on the other hand came in at Rs 35 bn (up 22.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (2QFY19); Net Profit Up 59.3% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 59.3% YoY). Sales on the other hand came in at Rs 31 bn (up 24.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Sep 20, 2019 (Close)

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES 5-YR ANALYSIS

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS